Filip Borgions
Direttore Tecnico/Scientifico/R&S presso ARGENX SE
Posizioni attive di Filip Borgions
Società | Posizione | Inizio | Fine |
---|---|---|---|
ARGENX SE | Direttore Tecnico/Scientifico/R&S | 01/01/2015 | - |
Storia della carriera di Filip Borgions
Precedenti posizioni note di Filip Borgions
Società | Posizione | Inizio | Fine |
---|---|---|---|
Thrombogenics, Inc.
Thrombogenics, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Oxurion NV, Thrombogenics, Inc. operates as a biotechnology company that delivers innovative treatments for diseases of the back of the eye, with a focus on diabetic eye disease. The company is based in New York, NY. | Corporate Officer/Principal | - | - |
Formazione di Filip Borgions
Katholieke Universiteit Leuven | Doctorate Degree |
Statistiche
Distribuzione geografica
Paesi Bassi | 2 |
Belgio | 2 |
Stati Uniti | 2 |
Posizioni
Chief Tech/Sci/R&D Officer | 1 |
Doctorate Degree | 1 |
Undergraduate Degree | 1 |
Settori
Health Technology | 2 |
Consumer Services | 2 |
Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
ARGENX SE | Health Technology |
Aziende private | 1 |
---|---|
Thrombogenics, Inc.
Thrombogenics, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Oxurion NV, Thrombogenics, Inc. operates as a biotechnology company that delivers innovative treatments for diseases of the back of the eye, with a focus on diabetic eye disease. The company is based in New York, NY. | Commercial Services |
- Borsa valori
- Insiders
- Filip Borgions
- Esperienza